Significance of fractional exhaled nitric oxide combined with serum procalcitonin and C-reactive protein in evaluation of elderly asthma

Ji-zhen Wu , Li-jun Ma , Li-min Zhao , Xiao-yu Zhang , Xian-liang Chen , Hong-yan Kuang

Current Medical Science ›› 2013, Vol. 33 ›› Issue (2) : 185 -188.

PDF
Current Medical Science ›› 2013, Vol. 33 ›› Issue (2) : 185 -188. DOI: 10.1007/s11596-013-1094-y
Article

Significance of fractional exhaled nitric oxide combined with serum procalcitonin and C-reactive protein in evaluation of elderly asthma

Author information +
History +
PDF

Abstract

Bronchial asthma is a common chronic airway inflammatory disease. Asthma is associated with high mortality, especially in the elderly patients. Repeated exacerbations cause disease progression. Therefore, identifying the onset of acute elderly asthma as soon as possible and giving the effective treatment is crucial to improve the prognosis. This study was to investigate the significance of fractional exhaled nitric oxide (FeNO) combined with serum procalcitonin (PCT) and C-reactive protein (CRP) in the evaluation of elderly asthma. A total of 120 elderly patients with an acute attack of asthma from July, 2010 to May, 2012 were studied. On presentation, FeNO, serum PCT and CRP concentrations were measured and sputum culture was also performed. The elderly patients were re-evaluated when they had returned to their stable clinical state. The elderly patients were classified into two groups: positive bacterial culture group (A) and negative bacterial culture group (B). The results showed that: (1) In patients with an acute exacerbation of asthma, 48 (40%) patients had positive sputum bacterial culture and 72 (60%) had negative sputum bacterial culture. (2) The levels of FeNO in patients with acute exacerbation of asthma were significantly higher than in those with no acute exacerbation state (63.8±24.6 vs. 19±6.5 ppb, P<0.05). There was no significant difference in FeNO between group A and group B (P>0.05). (3) The levels of PCT and CRP in group A patients with an acute exacerbation of asthma were significantly higher (P<0.05) than in group B (for PCT: 27.46±9.32 vs. 7.85±3.52 ng/mL; for CRP: 51.25±11.46 vs. 17.11±5.87 mg/L, respectively). When they had returned to stable clinical state, the levels of PCT and CRP in group A were decreased significantly (P<0.05), and those in group B had no significant change (P>0.05) when compared with the exacerbation group. There were no significant differences in the levels of PCT and CRP between the two groups in non-acute exacerbation state (P>0.05). These results suggest that the increase in FeNO indicates the acute exacerbation of asthma, and the elevation of serum PCT and CRP levels may be associated with bacterial infection.

Keywords

elderly / asthma / fractional exhaled nitric oxide / procalcitonin / C-reactive protein / bacterial infection

Cite this article

Download citation ▾
Ji-zhen Wu, Li-jun Ma, Li-min Zhao, Xiao-yu Zhang, Xian-liang Chen, Hong-yan Kuang. Significance of fractional exhaled nitric oxide combined with serum procalcitonin and C-reactive protein in evaluation of elderly asthma. Current Medical Science, 2013, 33(2): 185-188 DOI:10.1007/s11596-013-1094-y

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

SpanierAJ, HornungRW, KahnRS, et al.. Seasonal variation and environmental predictors of exhaled nitric oxide in children with asthma. Pediatr Pulmonol, 2008, 43(6): 576-583

[2]

FranklinPJ, StickSM. The value of FeNO measurement in asthma management: the motion against FeNO to help manage childhood asthma-reality bites. Paediatr Respir Rev, 2008, 9(2): 122-126

[3]

TsurikisawaN, OshikataC, TsuburaiT, et al.. Markers for step-down of inhaled orticosteroid therapy in adult asthmatics. Allergol Int, 2012, 61(3): 419-429

[4]

SchleichFN, AsandeiR, ManiseM, et al.. Is FENO 50 useful diagnostic tool in suspected asthma?. Int J Clin Pract, 2012, 66(2): 158-165

[5]

AndersonWJ, ShortPM, WilliamsonPA, et al.. Inhaled corticosteroid dose response using domiciliary exhaled nitric oxide in persistent asthma: the FENO type trial. Chest, 2012, 142(6): 1553-1561

[6]

O’ByrnePM. Global guidelines for asthma management: summary of the current status and future challenges. Pol Arch Med Wewn, 2010, 120(12): 511-517

[7]

PavordID, PizzichiniMM, PizzichiniE, et al.. The use of induced sputum to investigate airway inflammation. Thorax, 1997, 52(6): 498-501

[8]

MajidH, KaoC. Utility of exhaled nitric oxide in the diagnosis and management of asthma. Curr Opin Pulm Med, 2010, 6(1): 42-47

[9]

BernsteinJA, DavisB, Alvarez-PueblaMJ, et al.. Is exhaled nitric oxide a useful adjunctive test for assessing asthma?. J Asthma, 2009, 46(9): 955-960

[10]

HewittRS, ModrichCM, CowanJO, et al.. Outcomes using exhaled nitric oxide measurements as an adjunct to primary care asthma management. Prim Care Respir J, 2009, 8(4): 320-327

[11]

MahutB, TrinquartL, BokovP, et al.. The link between exhaled NO and bronchomotor tone depends on the dose of inhaled steroid in asthma. Respir Med, 2010, 104(7): 945-950

[12]

RusswurmS, WiederholdM, OberhofferM, et al.. Procalcitonin as monocytic marker for early diagnosis in septic abortion. Geburtsh Neonatol, 2000, 204(1): 34-38

[13]

BeekerKL, SniderR, NylenES. Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Crit Care Med, 2008, 36(3): 941-952

[14]

SimonL, GauvinF, AmreDK, et al.. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis, 2004, 39(2): 206-217

[15]

StolzD, Christ-CrainM, BringisserR, et al.. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy. Chest, 2007, 131(9): 9-19

AI Summary AI Mindmap
PDF

110

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/